CRISPR has transformed biology by making it possible to edit DNA with unprecedented precision. What began as a remarkable scientific discovery has rapidly evolved into one of the most promising technologies for treating genetic diseases.
In this lecture, Dr. Daniël Warmerdam will discuss how CRISPR works and how it is opening new possibilities for treating patients. Through real-world examples, he will illustrate how researchers are developing therapies that aim to correct the underlying genetic cause of disease, rather than simply treating symptoms.
The lecture will also explore the challenges that remain. Although the science is advancing rapidly, many patients still cannot benefit from these innovations. Why is that? What barriers stand in the way? And what role can researchers, policymakers, industry, patients and society play in ensuring that these breakthrough therapies become available, accessible and affordable, particularly for patients with unmet medical needs?
This is not a WORK event.
Are you interested in the MSc Chemistry or MSc Life Science & Technology programme?
Find out more about the programmes, career prospects & how to apply.